Results of a pharmacoeconomic analysis of the rationality of the use of acute myeloid leukemia chemotherapy regimens with the use of various doses of cytarabine
Hanna Panfilova, Anastasiya Goncharova, Iuliia Korzh, Irina Zhirova, Oksana Tsurikova and Natalia Bezuglaia